CXCR4 and ovarian neoplasm: Consequently, their findings suggest that miR-9 may exert inhibitory effects on ERK1/2 and MMP-9 expression by targeting the SDF-1/CXCR4 pathway, thereby impeding the development and progression of ovarian tumors (He et al., 2017).